Reddie & Grose LLP

Patents & Plant Varieties

Partner

Michael has acted for clients from around the world, including small and medium-sized companies, multinationals and universities. In addition to patent drafting and prosecution, he assists clients with due diligence and patent reports, notably for private or public fund raising, patent portfolio advice, and issues such as freedom to operate and patent validity.

Recently, Michael has contributed to The CIPA Guide to Patents Acts, 9th edition. This publication combines knowledge from 30 legal professionals, all individually selected for their proficient knowledge.

Michael is one of the IAM Top 1000 patent attorneys.

Michael originally joined Reddie & Grose in 2001, and following a short period with a UK-based biotechnology and pharmaceuticals specialist firm, he returned in 2008 and was made a partner in 2010.

Michael’s IP practice is focused in the life sciences fields, and includes biotechnology, microbiology, molecular biology, genetic engineering, immunology (including vaccines), enzymology, pharmaceuticals, medical instruments and plant protection (including plant variety rights).

Before entering the patent profession, Michael gained extensive technical knowledge and experience through his doctoral research at the University of St Andrews into the molecular genetics of sulphate assimilation, followed by three years of postdoctoral research at the John Innes Centre, Norwich, in plant molecular biology and genomics.

Chartered Institute of Patent Attorneys (CIPA)

Institute of Professional Representatives before the European Patent Office

Life Sciences Committee of CIPA

European Design Attorney (2003)

European Patent Attorney (2003)

Chartered Patent Attorney (2003)

PhD in Molecular Genetics, University of St Andrews

MSc degree in Biochemistry and Biotechnology, University of Natal

BSc (Hons) degree in Cell Biology, University of Natal

Away from the office, Michael enjoys motorcycling, walking, music, art, travelling, and being with his family.